An interventional study of Exercise Training and Exercise Cessation in Aging, Exercise and Cardiovascular Disease, sponsored by Baltimore VA Medical Center. Completed at 1 site in United States. Open to participants aged 50 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by Baltimore VA Medical Center · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Endothelial Progenitor Cells (EPCs) are circulating cells released from bone marrow which are important for maintaining cardiovascular health. The prevalence of cardiovascular disease in older adults is associated with reduced circulating EPC numbers. Studies have shown reduced EPC number and function in old vs. young individuals, and endurance exercise training increases EPC number and function in young adults. Oxidative stress adversely affects endothelial cells and preliminary evidence indicates that oxidative stress negatively affects EPC function. Conversely, regular exercise reduces markers of oxidative stress and may enhance EPC function in older adults. The investigators hypothesize that older endurance-trained athletes and matched sedentary individuals will have markedly divergent EPC function and that altering the physical activity levels of both groups will move them to intermediate points between these two extremes. The investigators also propose that the investigators can "mimic" the effect of exercise training on EPC function in cell culture by altering intracellular levels of a key enzyme and a signaling molecule which the investigators have shown to regulate EPC function with respect to exercise training in young individuals.
5,376 studies on the registry are indexed under Cardiovascular Diseases; 940 are open to participants now.
This study's enrollment of 33 is below the median of 100 across 3,086 interventional studies indexed under Cardiovascular Diseases.
Browse Cardiovascular Diseases studies →Baltimore VA Medical Center is the lead sponsor of 19 studies on the registry; 2 are open to participants now.
Compared within Cardiovascular Diseases, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Motor Activity. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Postmenopausal
Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: Exercise Training
Other: Exercise Cessation
2 weeks of daily aerobic exercise training
Stopping all exercise for 2 weeks
Baseline Flow-mediated Dilation
Percent dilation of the brachial artery in response to an increase in blood flow.
Time frame: Baseline
Final Flow-mediated Dilation
Percent dilation of the brachial artery in response to an increase in blood flow.
Time frame: Day 15
Final Endothelial Progenitor Cell Number
The number of cells in blood samples that expressed both the Cluster of Differentiation 34 protein and the Kinase Insert Domain Receptor protein
Time frame: Day 15
Baseline Endothelial Progenitor Cell Number
The number of cells in blood samples that expressed both the Cluster of Differentiation 34 protein and the Kinase Insert Domain Receptor protein
Time frame: Baseline
| Milestone | Sedentary Older Adults | Older Endurance Athletes |
|---|---|---|
| Started | 14 | 19 |
| Completed | 12 | 17 |
| Not completed | 2 | 2 |
Percent dilation of the brachial artery in response to an increase in blood flow.
| percent of baseline diameter | Sedentary Older Adults | Older Endurance Athletes |
|---|---|---|
| Baseline Flow-mediated Dilation | 10.3 ± 4.7 | 10.1 ± 5.8 |
Percent dilation of the brachial artery in response to an increase in blood flow.
| percent of baseline diameter | Sedentary Older Adults | Older Endurance Athletes |
|---|---|---|
| Final Flow-mediated Dilation | 16.2 ± 4.6 | 8.8 ± 5.1 |
The number of cells in blood samples that expressed both the Cluster of Differentiation 34 protein and the Kinase Insert Domain Receptor protein
| Cells per 100,000 total cells | Sedentary Older Adults |
|---|---|
| Final Endothelial Progenitor Cell Number | 50.7 ± 40.7 |
The number of cells in blood samples that expressed both the Cluster of Differentiation 34 protein and the Kinase Insert Domain Receptor protein
| Cells per 100,000 total cells | Sedentary Older Adults |
|---|---|
| Baseline Endothelial Progenitor Cell Number | 24.8 ± 22.6 |
Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Sedentary Older Adults | — | 0/14 (0%) | 0/14 (0%) |
| Older Endurance Athletes | — | 0/19 (0%) | 0/19 (0%) |
| Age, Continuous(years) | Sedentary Older Adults | Older Endurance Athletes | Total |
|---|---|---|---|
| Mean | 61 ± 8 | 62 ± 7 | 62 ± 7 |
| Sex: Female, Male(Participants) | Sedentary Older Adults | Older Endurance Athletes | Total |
|---|---|---|---|
| Female | 9 | 6 | 15 |
| Male | 5 | 13 | 18 |
| Race (NIH/OMB)(Participants) | Sedentary Older Adults | Older Endurance Athletes | Total |
|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 |
| Asian | 1 | 1 | 2 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 |
| Black or African American | 4 | 6 | 10 |
| White | 9 | 11 | 20 |
| More than one race | 0 | 1 | 1 |
| Unknown or Not Reported | 0 | 0 | 0 |
| Flow-mediated dilation(Percent of baseline diameter) | Sedentary Older Adults | Older Endurance Athletes | Total |
|---|---|---|---|
| Mean | 10.3 ± 4.7 | 10.1 ± 5.8 | 10.2 ± 5.2 |
The record gives a start of Jul 2011, a primary completion of Nov 2014 and a completion of Jul 2024. It does not say whether these dates are actual or estimated.
Results were first posted in Nov 2026, 12 years after primary completion.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Baltimore VA Medical Center